Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And who are those people? Pretty strong g accusations. If you don’t have specifics, it is all speculation.
In May of 2021 they had the license for about three months at that time. Things take time. I am patient. They will get it done.
Or maybe not.
The company announced the grant of exclusive worldwide license from the National Institute of Health for repurposing Metformin to treat degenerative eye disease on February 4, 2021. Dr. Kapil Bharti from the National Eye Institute was added to CUBT’s Advisory Board on April 29, 2021. Dr Bharti has been involved in the development of the Metformin eye drop solution.
The company’s goal is to bring their solutions to a monetization event within a two year time frame. It has been just over one year since they were awarded the worldwide license and less than one year since Dr. Bharti joined the board. Give this management team time. They know what they are doing imo. And they are on track despite the delay in filing the IND. It is a rigorous process they are going through.
CUBT the comeback kid. What a recovery. Guess those bad loan terms were so bad after all. Most people see the potential with what the company owns. Only regret is not adding yesterday.
Indeed. Shares were stolen at great prices yesterday. People need to know what they own.
Apparently the market doesn’t care too much about the terms. The stock price is exactly where it was when I added last week. It sounds like to me you place zero value on the worldwide license CUBT has to a Metformin eye drop treatment for AMD, the initiative of which is being lead by Dr. Bharti who works at the National Eye Institute (part of the National Health Institute) and is an Advisor to CUBT management on its development. I am thinking more people are more intrigued by this potential than the terms of a short term loan to fund their research which is needed to advance to the product stage eventually.
You may not have been stealing shares. Some people took full advantage of the over reaction to the news and got some really cheap shares. I call that stealing shares based on fear mongering tactics of some. Seen this way too many times before big moves north which I am fully expecting here.
It should bother me? Who is anyone to tell me what should or should not bother me? If it bothers you fine. If this becomes a $10 stock praise the good Lord is what I would say because I would have made $$. I really don’t care what other people make. If you do then so be it. Just don’t project your values on me and tell me what should bother me. Not your place.
Buy when there is blood in the water. I will be at EOD. Don’t let anyone steal your shares. It is a $1M bridge loan like others have said to keep. Money needed to keep things moving forward.
To make a comment that The not exist in a year is one of the most ridiculous comments made to date on this board. If not ridiculous then certainly one made on wild speculation about lawsuits. It is laughable.
CUBT will not be late on the 10K. Lots of lazy people shoot from the hip and make comments based on emotion and not facts. Google is a really good tool to answer questions such as when 10K’s are due.
The report is not late. Don’t spew lies.
I just take it as it comes. I saw that .0598 ask and liked the price and bought. Hopefully news hits sooner than later. We shall see. Was glad to pick up whatever amount I could at that ask price.
Added some here at .0598. Only filled 17K of 50K order. If you want any volume here you won’t get many at these prices.
“The research was done by the National Eye Institute, which is part of the National Institutes of Health.”
Like reading this in the article. Same federal agency that CUBT will soon be partnering with on their Metformin eye drop research.
Personally I could care less what people on this board think about anything. We are all responsible for our own decisions. I am in this because I believe in where they are going and the value of the licenses they hold. What people were saying two weeks ago, two months ago or last year is immaterial to me. I know what I own and am being patient on their execution. It took me two years to get a tax refund back from the federal government. Entering into a relationship with the NEI, which I believe the company is close to accomplishing, takes time. Lots of red tape and hoops to jump through. With that said I can certainly understand one’s frustration and impatience. For me I ain’t too worried about the delay in news. It will come when ready.
I’ve been receiving a lot of friend requests and follows from Huntpost subs. The upside on this social site is enormous.
All good. I am sure one of many things we have in common is that we are both long WDLF. GLTA who are long.
The reason I am asking is to determine whether I should expect financials for Q4 tomorrow for WDLF. I generally don’t like to post expectations of financial disclosures if they are not going to happen. I do not expect a 10Q for Q4 2021 by tomorrow.
The exact filing dates depend on the organization’s fiscal year, but it is necessary to file three 10-Q reports each year.1 A 10-Q for the final quarter of the year is not required: After the fourth quarter, a company files Form 10-K, an annual report, instead. The 10K is not due tomorrow and based on their disclosure timing history I don’t see any Q4 financials being released this week.
I guess we will know tomorrow what their plans are.
I am simply saying that to expect the year end report by 2/15/22 may be premature. I am not concerning myself with the past. I am attempting to verify if your comment is accurate.
Last year the 10K was filed 3/31/21 for year end 12/31/20. There was no 10Q. Did their filing status change from last year?
I believe the 10K is 60 days.
It’s all dependent on news and subsequent volume.
It was right before the Super Bowl weekend to be exact. One year ago. We’re due.
Added a few today at .074. I agree good zone. Patience will pay off. Looking forward to hearing CEO Garr’s words about the NEI partnership come to fruition. Dots align for this Metformin eye drop to move forward. Once this is announced, and I am confident it will, CUBT would then be in partnership with the gold standard organization in the world in the area of eye research.
Still coming up zero on short interest looks like.
Let’s break through .08.
The best way not to be caught off guard is to sell your position. That will ensure your desired outcome, to not be caught off guard. Otherwise there is no way to really prevent yourself from being caught off guard, wouldn’t you agree?
That is what I asking. Thank you for clarifying.
Does WDLF still get the profit % split and equity stake in the event of an acquisition versus some other type of liquidity event? That is significant if that is the case.
The article posted here on the cannabis space is ridiculous and has no connection to CUBT.
$QSAM Very big step today. Priority Review Vouchers, if obtained, are typically with north of $100M. Current market cap is $13M. Way undervalued here.
Deep thoughts by Jack Handy.
There’s a lot more owners of the stock that do not post on iHub than those that do. I have buyers are not driving the stock in my opinion
The stock moved based on someone wanting in at these prices. There was no pump. So the question, what is wrong with getting excited when a holding actually moves in a positive direction without news. The alternative is to go down. No thanks. Some people are impossible to please.
Some here will be griping even when it hits $.50. It’s a given.
If anyone wants any big volume purchase they will have to pay.
My hunch is that the 1M share bid at .0596 did not get their shares early in week and they upped the ante on Friday. Some peeps wanting in.